ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort.

Chia-Hua Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.